Literature DB >> 29716755

Description of human AAA by cytokine and immune cell aberrations compared to risk-factor matched controls.

S Keisin Wang1, Linden A Green2, Ashley R Gutwein2, Natalie A Drucker2, Raghu L Motaganahalli2, Alok K Gupta2, Andres Fajardo2, Michael P Murphy3.   

Abstract

BACKGROUND: The pathogenesis driving the formation of abdominal aortic aneurysms continues to be poorly understood. Therefore, we systemically define the cytokine and circulating immune cell environment observed in human abdominal aortic aneurysm compared with risk-factor matched controls.
METHODS: From 2015 to 2017, a total of 274 patients donated blood to the Indiana University Center for Aortic Disease. Absolute concentrations of circulating cytokines were determined, using enzyme-linked immunosorbent assays while the expression of circulating immune cell phenotypes were assayed via flow cytometric analysis.
RESULTS: Human abdominal aortic aneurysm is characterized by a significant depletion of the antigen-specific, CD4+ Tr1 regulatory lymphocyte that corresponds to an upregulation of the antigen-specific, inflammatory Th17 cell. We found no differences in the incidence of Treg, B10, and myeloid-derived suppressor regulatory cells. Similarly, no disparities were noted in the following inflammatory cytokines: IL-1β, C-reactive protein, tumor necrosis factor α, interferon γ, and IL-23. However, significant upregulation of the inflammatory cytokines osteopontin, IL-6, and IL-17 were noted. Additionally, no changes were observed in the regulatory cytokines IL-2, IL-4, IL-13, TNF-stimulated gene 6 protein, and prostaglandin E2, but we did observe a significant decrease in the essential regulatory cytokine IL-10.
CONCLUSION: In this investigation, we systematically characterize the abdominal aortic aneurysm-immune environment and present preliminary evidence that faulty immune regulation may also contribute to aneurysm formation and growth.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29716755      PMCID: PMC6056326          DOI: 10.1016/j.surg.2018.03.002

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  38 in total

1.  Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.

Authors:  M Mosorin; J Juvonen; F Biancari; J Satta; H M Surcel; M Leinonen; P Saikku; T Juvonen
Journal:  J Vasc Surg       Date:  2001-10       Impact factor: 4.268

Review 2.  Current concepts in the pathogenesis of abdominal aortic aneurysm.

Authors:  Gorav Ailawadi; Jonathan L Eliason; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2003-09       Impact factor: 4.268

3.  Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

Review 4.  Humoral immunity and complement effector mechanisms after lung transplantation.

Authors:  K Budding; E A van de Graaf; H G Otten
Journal:  Transpl Immunol       Date:  2014-09-03       Impact factor: 1.708

5.  The role of inflammation in nonspecific abdominal aortic aneurysm disease.

Authors:  C M Brophy; J M Reilly; G J Smith; M D Tilson
Journal:  Ann Vasc Surg       Date:  1991-05       Impact factor: 1.466

6.  Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response.

Authors:  A E Koch; G K Haines; R J Rizzo; J A Radosevich; R M Pope; P G Robinson; W H Pearce
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

7.  Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment.

Authors:  Ashish K Sharma; Guanyi Lu; Andrea Jester; William F Johnston; Yunge Zhao; Vanessa A Hajzus; M Reza Saadatzadeh; Gang Su; Castigliano M Bhamidipati; Gaurav S Mehta; Irving L Kron; Victor E Laubach; Michael P Murphy; Gorav Ailawadi; Gilbert R Upchurch
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

8.  Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study.

Authors:  B Timothy Baxter; William H Pearce; Eugene A Waltke; Fred N Littooy; John W Hallett; K Craig Kent; Gilbert R Upchurch; Elliot L Chaikof; Joseph L Mills; Beverly Fleckten; G Matt Longo; Jason K Lee; Robert W Thompson
Journal:  J Vasc Surg       Date:  2002-07       Impact factor: 4.268

9.  An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK).

Authors:  Colin D Bicknell; Gaia Kiru; Emanuela Falaschetti; Janet T Powell; Neil R Poulter
Journal:  Eur Heart J       Date:  2016-07-01       Impact factor: 29.983

Review 10.  The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.

Authors:  Chengxin Luo; Hu Zhang
Journal:  Mediators Inflamm       Date:  2017-08-09       Impact factor: 4.711

View more
  4 in total

1.  Reversal of elastase-induced abdominal aortic aneurysm following the delivery of nanoparticle-based pentagalloyl glucose (PGG) is associated with reduced inflammatory and immune markers.

Authors:  Saphala Dhital; Charles D Rice; Naren R Vyavahare
Journal:  Eur J Pharmacol       Date:  2021-09-10       Impact factor: 5.195

2.  Sex-Based Differences Among Experimental Swine Abdominal Aortic aneurysms.

Authors:  J Michael Cullen; Alexander H Shannon; Guanyi Lu; Gang Su; Michael D Spinosa; William G Montgomery; Gorav Ailawadi; Morgan Salmon; Gilbert R Upchurch
Journal:  J Surg Res       Date:  2020-12-17       Impact factor: 2.192

3.  Systems Approach to Study Associations between OxLDL and Abdominal Aortic Aneurysms.

Authors:  Łukasz Gutowski; Kaja Gutowska; Maria Pioruńska-Stolzmann; Piotr Formanowicz; Dorota Formanowicz
Journal:  Int J Mol Sci       Date:  2019-08-11       Impact factor: 5.923

4.  Human Umbilical Cord Mesenchymal Stem Cells Attenuate Abdominal Aortic Aneurysm Progression in Sprague-Dawley Rats: Implication of Vascular Smooth Muscle Cell Phenotypic Modulation.

Authors:  Hao Wen; Mingjing Wang; Shiqiang Gong; Xintong Li; Jinze Meng; Jie Wen; Yifei Wang; Shuqing Zhang; Shijie Xin
Journal:  Stem Cells Dev       Date:  2020-07-13       Impact factor: 3.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.